Drug news
FDA approves FibroScan Elastography Imaging system(Echosens) for non-invasive liver disease diagnosis
The FibroScan device from Echosens has received 510(k) clearance from the FDA for use in non-invasive liver disease diagnosis. Based on a technology called Transient Elastography, FibroScan assesses liver shear wave speed and equivalent stiffness in a rapid, simple, non-invasive and totally painless way. Initially introduced in the European market in 2003, it has received market clearances in China, Canada, Brazil and Japan.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins